BamSEC and AlphaSense Join Forces
Learn More

Cephalon Inc

Formerly NASDAQ: CEPH
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 16 pages Cephalon, Inc. 2011 Equity Compensation Plan
12/34/56
EX-10.29(C)
from 10-K/A 101 pages Confidential Material Appearing in This Document Has Been Omitted and Filed Separately With the Securities and Exchange Commission in Accordance With the Securities Act of 1933, as Amended, and Rule 24b-2 Promulgated Thereunder. Omitted Information Has Been Replaced With Asterisks Development and Commercialization Agreement
12/34/56
EX-10.28
from 10-K/A 36 pages Confidential Material Appearing in This Document Has Been Omitted and Filed Separately With the Securities and Exchange Commission in Accordance With the Securities Act of 1933, as Amended, and Rule 24b-2 Promulgated Thereunder. Omitted Information Has Been Replaced With Asterisks Settlement and License Agreement
12/34/56
EX-10.1
from 10-Q 93 pages Confidential Material Appearing in This Document Has Been Omitted and Filed Separately With the Securities and Exchange Commission in Accordance With the Securities Act of 1933, as Amended, and Rule 24b-2 Promulgated Thereunder. Omitted Information Has Been Replaced With Asterisks Agreement and Plan of Merger Among: Cephalon, Inc., a Delaware Corporation; C2011merger Sub, Inc., a Delaware Corporation; Gemin X Pharmaceuticals, Inc., a Delaware Corporation; and Shareholder Representative Services LLC as the Stockholders’ Representative Dated as of March 20, 2011
12/34/56
EX-10.4
from 8-K 11 pages Amendment to Employment Contract
12/34/56
EX-10.3
from 8-K 13 pages Executive Severance Agreement
12/34/56
EX-10.2
from 8-K 13 pages Executive Severance Agreement
12/34/56
EX-10.1
from 8-K 12 pages Form of Indemnification Agreement
12/34/56
EX-10.1
from 8-K 6 pages Cephalon, Inc. Consulting Agreement
12/34/56
EX-10.29(C)
from 10-K 61 pages Development and Commercialization Agreement
12/34/56
EX-10.29(B)
from 10-K 17 pages Subscription Deed Date 2010 Parties Background Operative Provisions 1. Definitions and Interpretation 1.1 Definitions
12/34/56
EX-10.29(A)
from 10-K 21 pages Stock Purchase Agreement
12/34/56
EX-10.28
from 10-K 28 pages Settlement and License Agreement
12/34/56
EX-10.1
from 8-K 3 pages Cephalon, Inc. 2011 Management Incentive Compensation Plan
12/34/56
EX-10.4
from 10-Q 16 pages Employment Contract
12/34/56
EX-10.1
from 8-K 12 pages Executive Severance Agreement
12/34/56
EX-10.3
from 8-K ~5 pages Summary of Oral Agreement for Payment of Services Between Cephalon, Inc. and Its Board of Directors Dated May 20, 2010
12/34/56
EX-10.2
from 8-K 14 pages Cephalon, Inc. 2010 Employee Stock Purchase Plan
12/34/56
EX-10.1
from 8-K 2 pages Amendment 2010-1 to the Cephalon, Inc. 2004 Equity Compensation Plan
12/34/56
EX-10.2
from 10-Q 3 pages Third Amendment to Option Agreement Dated January 13, 2009 Between Cephalon, Inc. and Ception Therapeutics, Inc
12/34/56